Clinical and basal aspects of anemia during antiviral therapy for hepatitis C

Clinical and basal aspects of anemia during antiviral therapy for hepatitis C

Background and Rationale. Anemia is a major side effect of combination therapy for chronic hepatitis C. In this study, severity, potential risk factors for and potential underlying mechanisms of anemia were evaluated.Patients and methods. 44 chronic hepatitis C patients on interferon-ribavirin treat...

Full description

Bibliographic Details
Main Authors: Hanneke van Soest, Willem Renooij, Karel J. van Erpecum
Format: Article
Language:English
Published: Elsevier 2009-10-01
Series:Annals of Hepatology
Subjects:
Erythropoietin
Interferon
Ribavirin
Hemolysis
Phospholipid
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119317442

Similar Items

Similar Items